Disgraced Clone Expert Barred from Work
By The West Australian,
The West Australian
| 07. 31. 2008
South Korea will not allow disgraced cloning expert Hang Woo-suk to resume human stem cell research, it has been reported.
Hwang's request was turned down by the country's national committee on bioethics, Yonhap news agency reported on Thursday.
The health ministry declined to comment on the report but said it would brief the media on Friday.
"He engaged in unethical and wrongful acts in the past and the committee decided to reject it," a source who took part in the committee meeting was quoted by Yonhap as saying.
"One committee member strongly argued that it would bring shame on the whole country," the source said.
Hwang's claims that he created the first human stem cells through cloning were ruled to be bogus, and he is banned from research using human eggs.
But the scientist is now engaged in animal cloning at the Sooam Biotech Research Foundation, which in December asked for the green light to begin a new embryonic stem cell research project using aborted human eggs.
Still on trial for fraud, embezzlement, ethical breaches and other charges, Hwang has...
Related Articles
By Nicholas Wade, The New York Times | 04.30.2026
“J. Craig Venter” via Wikimedia Commons licensed under CC by 2.5
J. Craig Venter, a scientist and entrepreneur who raced to decode the human genome, died on Wednesday in San Diego. He was 79.
His death was announced by...
By Susan Dominus, The New York Times Magazine | 04.27.2026
Why are babies born young? The most natural phenomenon on earth is actually hard to explain — at least on a cellular level. Consider this problem: The components of conception are old. When a woman gets pregnant, she has...
By Jonathan Basile, Los Ángeles Review of Books | 04.29.2026
WILLIAM BATESON, a foundational figure in the science of genetics at the turn of the last century, once recounted the response of a Scottish soldier to one of his public lectures: “Sir, what ye’re telling us is nothing but Scientific...
By Rob Stein, NPR | 04.23.2026
The Food and Drug Administration approved the first gene therapy to restore hearing for people who were born deaf.
The decision, while only immediately affecting people born with a very rare form of genetic deafness, is being hailed as...